Atanasio
Pandiella Alonso
University of Toronto
Toronto, CanadáPublicaciones en colaboración con investigadores/as de University of Toronto (26)
2022
-
Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis
Therapeutic Advances in Medical Oncology, Vol. 14
2020
-
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Breast Cancer Research, Vol. 22, Núm. 1
-
Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis
Molecular Diagnosis and Therapy, Vol. 24, Núm. 2, pp. 143-151
2019
-
Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome
OncoImmunology, Vol. 8, Núm. 10
-
Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors
PLoS ONE, Vol. 14, Núm. 4
-
Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis
Frontiers in Oncology, Vol. 9
2018
-
Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: Understanding clinical trial results
Oncotarget, Vol. 9, Núm. 61, pp. 31915-31919
-
Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer
Breast Cancer Research and Treatment, Vol. 172, Núm. 3, pp. 725-732
-
Functional transcriptomic annotation and protein–protein interaction analysis identify EZH2 and UBE2C as key upregulated proteins in ovarian cancer
Cancer Medicine, Vol. 7, Núm. 5, pp. 1896-1907
2017
-
Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs
Molecular Diagnosis and Therapy, Vol. 21, Núm. 3, pp. 337-343
-
Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors
Oncotarget, Vol. 8, Núm. 13, pp. 21733-21740
-
Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors
PLoS ONE, Vol. 12, Núm. 5
-
Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers
Scientific Reports, Vol. 7, Núm. 1
2016
-
Circulating DNA and survival in solid tumors
Cancer Epidemiology Biomarkers and Prevention, Vol. 25, Núm. 2, pp. 399-406
-
In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: Role of mitotic kinases
Oncotarget, Vol. 7, Núm. 16, pp. 22865-22872
-
Neuregulin expression in solid tumors: Prognostic value and predictive role to anti-HER3 therapies
Oncotarget, Vol. 7, Núm. 29, pp. 45042-45051
-
Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer
Breast Cancer Research and Treatment, Vol. 156, Núm. 1
2015
-
Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer
Oncotarget, Vol. 6, Núm. 29, pp. 27923-27937
-
Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs: Systematic review and meta-analyses
Oncotarget, Vol. 6, Núm. 37, pp. 39538-39549
-
Tumor-Infiltrating lymphocytes in breast cancer: Ready for prime time?
Journal of Clinical Oncology